Reported Consolidated quarterly numbers for Panacea Biotec are:
Net Sales at Rs 128.93 crore in March 2023 down 8.38% from Rs. 140.73 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 12.68 crore in March 2023 down 101.02% from Rs. 1,237.47 crore in March 2022.
EBITDA stands at Rs. 9.39 crore in March 2023 up 135.92% from Rs. 26.14 crore in March 2022.
Panacea Biotec shares closed at 122.40 on May 29, 2023 (NSE) and has given -12.60% returns over the last 6 months and -14.82% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 128.93 | 115.20 | 140.73 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 128.93 | 115.20 | 140.73 | | EXPENDITURE | | Consumption of Raw Materials | 59.51 | 48.07 | 52.33 | | Purchase of Traded Goods | -- | 1.96 | 4.92 | | Increase/Decrease in Stocks | -2.03 | -2.25 | 11.85 | | Power & Fuel | -- | -- | -- | | Employees Cost | 30.55 | 32.02 | 47.13 | | Depreciation | 9.51 | -16.55 | 11.15 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 46.57 | 44.04 | 54.69 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -15.18 | 7.91 | -41.34 | | Other Income | 15.06 | 13.94 | 4.05 | | P/L Before Int., Excpt. Items & Tax | -0.12 | 21.85 | -37.29 | | Interest | 1.05 | 27.18 | 30.66 | | P/L Before Exceptional Items & Tax | -1.17 | -5.33 | -67.95 | | Exceptional Items | 19.38 | 27.77 | 1,676.21 | | P/L Before Tax | 18.21 | 22.44 | 1,608.26 | | Tax | 30.89 | 3.07 | 370.79 | | P/L After Tax from Ordinary Activities | -12.68 | 19.37 | 1,237.47 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -12.68 | 19.37 | 1,237.47 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -12.68 | 19.37 | 1,237.47 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.07 | 3.16 | 202.03 | | Diluted EPS | -2.07 | 3.16 | 202.03 | | EPS After Extra Ordinary | | Basic EPS | -2.07 | 3.16 | 202.03 | | Diluted EPS | -2.07 | 3.16 | 202.03 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
